2012
Jan: Invitation from the LMMCC. Luxemburg.
Vortrag I. Herr: Targeting of pancreatic cancer stem cells by bioactive agents from nutrition and marine sponges.
2011
Nov: AICR Conference on Food, Nutrition, Physical Activity and Cancer. Washington, USA.
Poster I. Herr: Involvement of autophagy in survival of pancreatic tumorigenic cells in oxygen- and nutrition-depleted environments.
Nov: 16th World Congress on Advances in Oncology. Rhodos, Greece.
Vortrag I.Herr: Identification and targeting of tumor-initiating cells in pancreatic cancer.
Okt: Arzt-Patienten-Tag an der Chirurgischen Universitätsklinik. Heidelberg, Germany.
Vortrag I.Herr: Nahrungsmittel, Ernährung, körperliche Bewegung und Krebs.
Sep: Deutscher Fachausschuss für Arznei-, Gewürz- und Aromapflanzen (DFA), Berlin, Germany.
Vortrag I. Herr: Glucosinolate aus der Familie der Kreuzblütler bei der Prävention und Therapie von Krebs.
Mär: Frontier-Symposium, University of Heidelberg, Heidelberg, Germany.
Vortrag I. Herr: Knochenmarkszellen aus Schwein zur Behandlung menschlicher Leberschäden?
2010
Nov: Perspectives for Translational Medicine in Heidelberg, Heidelberg, Germany
Vortrag I. Herr: Diverse functions of adult stem cells in gastrointestinal cancer
Nov: EORTC-NCI-AACR Kongress 2010, Berlin, Germany
Poster I. Herr: Sulforaphane enhances effects of sorafenib, quercetin, and chemotherapy toward pancreatic cancer stem-like cells.
Nov: EEBC 2010, Exercise, Energy Balance and Cancer, Heidelberg, Germany
Poster I. Herr: Autophagy may enable survival of pancreatic cancer stem cells in oxygen- and nutrition depleted tumor microenvironments
Nov: APA 2010, Annual Research Conference of the American Pancreatic Association, Chicago, USA
Poster I. Herr: Marine sponge Crambe crambe for efficient elimination of pancreatic cancer stem cells
Okt: AICR 2010, Annual Research Conference of the American Insititute of Cancer Research: Food, Nutrition, Physical Activity and Cancer, Washington D.C., USA
Poster I. Herr: Autophagy enables survival of pancreatic cancer stem cells in oxygen- and nutrition depleted tumor microenvironments
Okt: 15 th World Congress on Advances in Oncology and 13 th International Symposium on Molecular Medicine, Loutraki, Greece
Vortrag A. Salnikov
Okt: 6th Swiss Apoptosis Meeting, 2010, Bern, Switzerland
Poster S.Labsch: Sulforaphane potentiates gemcitabine mediated cytotoxicity towards cancer stem cells
Jul: 14 th International Congress of Immunology, Kobe, Japan
Vortrag & Poster A. Salnikov: Overexpression of TRAIL in lymphocytes enhances bispecific EpCAMxCD3 antibody immunotherapy against pancreatic tumor initiating cells.
Feb: Deutscher Krebskongress, Berlin, Germany
Vortrag I. Herr: Targeting of pancreatic cancer stem cells by sorafenib and broccoli-derived dietary ingredient sulforaphane
2009
Nov: Deutscher Pankreasclub, Heidelberg.
Vortrag A. Salnikov: Enhanced gene therapy with trail by specific antibody immuno therapy in advanced pancreatic cancer
Nov: APA - Annual Meeting, Honolulu, Hawaii, USA.
Poster I. Herr: Targeting of pancreatic cancer stem cells by chemopreventive agents
Nov: China Biomedical Innovations Conference 2009, Shanghai, China,
Vortrag A. Salnikov: Targeting of pancreatic carcinoma and CSCs by bispecific EpCAMxCD3 antibody.
Sep: Gordon Research Conference: Stem Cells and Cancer, Les Diablerets, Switzerland,
Poster A. Salnikov: Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma.
Mai: Mesenchymal Stromal Cells and Tumor Microenvironment: an update, Montpellier; France
Poster I. Herr: Influence of inflammation to the liver regenerative potential of MSCs in transplantation
2008
Nov: Annual Meeting of the American Pancreatic Association, Special Symposium: The Continuum from Chronic Pancreatitis to Pancreatic Cancer. Chicago, IL, USA.
Poster I. Herr: Sulforaphane eradicates pancreatic cancer stem cells by NF-KB.
Okt: 8th International Conference of Anticancer Research, Kos, Greece.
Vortrag I. Herr:
Okt: 2nd International Symposium on EpCAM and Cancer Stem Cell Markers, Tutzing, Munich, Germany
Vortrag A. Salnikov: Targeting of pancreatic carcinoma and CSCs by bispecific EpCAMxCD3 antibody.
Okt: 5th Heinrich F.C. Behr Symposium,“Stem Cells and Cancer,” DKFZ, Heidelberg, Poster Presentation
Poster G.,Kallifatidis: Profiling and targeting of cancer stem cells.
Sep: The Joint Annual Meeting of Immunology of the Austrian and German Societies, Vienna, Austria
Poster A. Salnikov: Bispecific EpCAMxCD3 antibody eradicates tumors in vivo and potently stimulates lymphocytes in 3D tumor recpmstrict syste, om vitro.
Mai: Onkologischer Arbeitskreis Heidelberg, Heidelberg
Vortrag I. Herr: Evaluation of human mesenchymal stem cells for anti-angiogenic therapy of pancreatic cancer
Feb: American Association for Cancer Research, AACR, Conference 'The Role of Cancer Stem Cells in the Initiation and Propagation of Tumorigenesis, Los Angeles, CA, USA
Teilnahme : A. Salnikov
Poster A. Salnikov: Migratory properties of CD133+ cancer stem cells from Huh 7 hepatocelllular carcinoma cell line
Poster G. Kallifatidis: Sulforaphane eradicates pancreatic cancer stem cells by NF-KB.
2007
Nov: Symposium "Pancreatic Cancer 2007: Stem Cells in Pancreas and Pancreatic Cancer", The American Pancreatic Association / Lustgarten Foundation, Chicago, IL, USA
Teilnahme I. Herr
Okt: 11.Onkologischer Alpengipfel, Loas, ÖsterreichVortrag I.Herr: KREBSSTAMMZELLEN IN SOLIDEN TUMOREN
Jul: 39. Meeting of the European Pancreatic Club, Newcastle Gatheshead, UK
Award for best basic science paper
Vortrag P.Büchler : BONE MARROW DERIVED MSC FOR THERAPY OF PANCREATIC CARCINOMA
Jun: 18. Workshop für experimentelle und klinische Lebertransplantation und Hepatologie, Wilsede, Germany
Vortrag B. Beckermann: Bone marrow derived mesenchimal stem cells for therapeutic intervention in liver disease
Poster A. Groth: On the TRAIL to therapeutic intervention in liver disease
Poster V. Rausch: Glucocorticoid-induced therapy resistance in solid tumors – a role for recurrence od HCC in liver transplantation
Jun: Einladung von Prof. Holger Kalthoff zum Seminar SFB 415 "Specificity and Pathophysiology of Signal Transduction Pathways", Kiel
Vortrag I. Herr
Apr: 14. Forschungskolloquium des Tumorzentrums Heidelberg/Mannheim, Heidelberg
Vortrag I. Herr: Evaluation humaner mesenchimaler Stammzellen zur antiangiogenen Therapie des Pankreaskarzinoms
Mär: Fourth International Conference on Tumor Microenvironment: Progression, Therapy and Prevention,Florence, Italy
Teilnahme : I. Herr
2006
Dez: Seminar Molecular Mechanisms in Health and Disease, DKFZ, Heidelberg
Vortrag G. Kallifatidis: Adenomatous Polyposis coli determines Sensivity to Histamine Deacetylase Inhibitor-induced Apoptosis
Dez: DKFZ PhD Poster Session, DKFZ, Heidelberg
Poster Präsentation G. Kallifatidis: Mesenchymal Stem Cells and TRAIL-induced Apoptosis in Prostate and Pancreatic Carcinomas
Dez: Universität Göttingen, Medizinische Fakultät, Göttingen
Vortrag I. Herr: Krebsstammzellen bei soliden Tumoren
Nov: Ernst Schering Foundation, Berlin
WORKSHOP ON CANCER STEM CELLS: NOVEL CONCEPTS AND PROSPECTS FOR TUMOR THERAPY
Teilnahme: G. Kallifatidis, B. Beckermann, I. Herr
Nov: Universitäts Kinderklinik, Heidelberg
Vortrag I. Herr: Molecular Strategies in Oncology
Okt: 11th World Congress on Advances in Oncology and 9th International Symposium on Molecular Medicine, Crete, Greece.
Vortrag I. Herr: Molecular Strategies in Oncology
Sep: Kongress der Deutschen Gesellschaft für Urologie 2006, CCH, Hamburg
Poster B. Beckermann: Mesenchimal Stem Cells and Angiogenesis in Prostate Cancer
Sep: XI. DKFZ PhD Retreat, Weil der Stadt
Poster G. Kallifatidis: Mesenchymal Stem Cells (MSCS) and TRAIL-induced Apoptosis in Prostate and Pancreatic Tumours (Poster design and presentation: 1st prize awarded)
Mai: DKFZ PhD Retreat, Weil der Stadt
Poster B. Beckermann: Mesenchymal Stem Cells and Angiogenesis in Pancreatic and Prostate Cancer
Jun: Istituto Toscano Tumori, Universität Genova, Florence, Italy.
Vortrag I. Herr: Molecular Strategies in Obcology with Topic Prostate Carcinoma
Mai: Universität Bochum, Pathologisches Institut, Medizinische Fakultät der Universität, Bochum
Vortrag I. Herr: Molecular Strategies in Obcology with Topic Prostate Carcinoma
Apr: Universität Freiburg, Medizinische Fakultät und Urologische Universitätsklinik, Freiburg
Vortrag I. Herr: Molecular Strategies in Obcology with Topic Prostate Carcinoma
Mär: Deutscher Krebskongress, Berlin
Vortrag I. Herr: Prospective Study of Glucocorticoid Co-medication and Risk od Resistance toward Cancer Therapy in solid Tumor Specimen, Cell Lines and Xenografts
Jan: Centre for Translational Oncology, Institute of Cancer and the CR-UK Clinical Centre, Barts and the London Queen Mary´s School of Medicine and Dentistry, London, UK.
Vortrag I. Herr: Therapy resistance od Tumors and Therapeutic Stategies
Mär: Heinrich F. C. Behr Symposium „Stem Cells and Cancer“, DKFZ, Heidelberg
Poster : G. Kallifatidis: Mesenchymal Stem Cells and TRAIL-induced Apoptosis in prostate Tumors
Vortrag und Poster: B. Beckermann: Mesenchymal Stem Cells and Angiogenesis in pancreatic and prostate Cancer
